| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | | Total Revenue | 27,181 | 26,251 | | Cost of Revenue | (14,346) | 14,346 | | | Gross Profit | 41,527 | 11,905 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 41,939 | 13,671 | | Non Recurring | 193 | 437 | | Others | 2,217 | 2,268 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (2,822) | (4,471) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,383 | (754) | | Earnings Before Interest And Taxes | (1,439) | (5,225) | | Interest Expense | 662 | 430 | | Income Before Tax | (2,101) | (5,655) | | Income Tax Expense | 147 | 123 | | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (2,248) | (5,778) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (2,248) | (5,778) | | Preferred Stock And Other Adjustments | 1,060 | (1,060) | | | Net Income Applicable To Common Shares | ($1,188) | ($6,838) |
|
0.16% Nasdaq 
Income Statement
